188 related articles for article (PubMed ID: 12532386)
1. Pulmonary gene delivery by chitosan-pDNA complex powder prepared by a supercritical carbon dioxide process.
Okamoto H; Nishida S; Todo H; Sakakura Y; Iida K; Danjo K
J Pharm Sci; 2003 Feb; 92(2):371-80. PubMed ID: 12532386
[TBL] [Abstract][Full Text] [Related]
2. Stability of chitosan-pDNA complex powder prepared by supercritical carbon dioxide process.
Okamoto H; Sakakura Y; Shiraki K; Oka K; Nishida S; Todo H; Iida K; Danjo K
Int J Pharm; 2005 Feb; 290(1-2):73-81. PubMed ID: 15664132
[TBL] [Abstract][Full Text] [Related]
3. Chitosan-interferon-β gene complex powder for inhalation treatment of lung metastasis in mice.
Okamoto H; Shiraki K; Yasuda R; Danjo K; Watanabe Y
J Control Release; 2011 Mar; 150(2):187-95. PubMed ID: 21185340
[TBL] [Abstract][Full Text] [Related]
4. [Local and systemic delivery of high-molecular weight drugs by powder inhalation].
Okamoto H; Danjo K
Yakugaku Zasshi; 2007 Apr; 127(4):643-53. PubMed ID: 17409693
[TBL] [Abstract][Full Text] [Related]
5. Dual imaging of pulmonary delivery and gene expression of dry powder inhalant by fluorescence and bioluminescence.
Mizuno T; Mohri K; Nasu S; Danjo K; Okamoto H
J Control Release; 2009 Mar; 134(2):149-54. PubMed ID: 19100298
[TBL] [Abstract][Full Text] [Related]
6. Optimized pulmonary gene transfection in mice by spray-freeze dried powder inhalation.
Mohri K; Okuda T; Mori A; Danjo K; Okamoto H
J Control Release; 2010 Jun; 144(2):221-6. PubMed ID: 20184930
[TBL] [Abstract][Full Text] [Related]
7. Non-viral dried powders for respiratory gene delivery prepared by cationic and chitosan loaded liposomes.
Colonna C; Conti B; Genta I; Alpar OH
Int J Pharm; 2008 Nov; 364(1):108-18. PubMed ID: 18775770
[TBL] [Abstract][Full Text] [Related]
8. Gene silencing in a mouse lung metastasis model by an inhalable dry small interfering RNA powder prepared using the supercritical carbon dioxide technique.
Okuda T; Kito D; Oiwa A; Fukushima M; Hira D; Okamoto H
Biol Pharm Bull; 2013; 36(7):1183-91. PubMed ID: 23811567
[TBL] [Abstract][Full Text] [Related]
9. Preparation and in vitro transfection efficiency of chitosan microspheres containing plasmid DNA:poly(L-lysine) complexes.
Aral C; Akbuga J
J Pharm Pharm Sci; 2003; 6(3):321-6. PubMed ID: 14738712
[TBL] [Abstract][Full Text] [Related]
10. Naked pDNA/hyaluronic acid powder shows excellent long-term storage stability and gene expression in murine lungs.
Ito T; Fukuhara M; Okuda T; Okamoto H
Int J Pharm; 2020 Jan; 574():118880. PubMed ID: 31811928
[TBL] [Abstract][Full Text] [Related]
11. Insertion of nuclear factor-kappaB binding sequence into plasmid DNA for increased transgene expression in colon carcinoma cells.
Thanaketpaisarn O; Nishikawa M; Okabe T; Yamashita F; Hashida M
J Biotechnol; 2008 Jan; 133(1):36-41. PubMed ID: 17961782
[TBL] [Abstract][Full Text] [Related]
12. Co-encapsulation of two plasmids in chitosan microspheres as a non-viral gene delivery vehicle.
Ozbas-Turan S; Aral C; Kabasakal L; Keyer-Uysal M; Akbuga J
J Pharm Pharm Sci; 2003; 6(1):27-32. PubMed ID: 12753728
[TBL] [Abstract][Full Text] [Related]
13. Establishment of an Evaluation Method for Gene Silencing by Serial Pulmonary Administration of siRNA and pDNA Powders: Naked siRNA Inhalation Powder Suppresses Luciferase Gene Expression in the Lung.
Ito T; Okuda T; Takayama R; Okamoto H
J Pharm Sci; 2019 Aug; 108(8):2661-2667. PubMed ID: 30954524
[TBL] [Abstract][Full Text] [Related]
14. Naked pDNA Inhalation Powder Composed of Hyaluronic Acid Exhibits High Gene Expression in the Lungs.
Ito T; Okuda T; Takashima Y; Okamoto H
Mol Pharm; 2019 Feb; 16(2):489-497. PubMed ID: 30092131
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of a new plasmid delivery system based on chitosan-sodium deoxycholate nanoparticles.
Cadete A; Figueiredo L; Lopes R; Calado CC; Almeida AJ; Gonçalves LM
Eur J Pharm Sci; 2012 Mar; 45(4):451-8. PubMed ID: 21986445
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo gene delivery using chitosan/hyaluronic acid nanoparticles: Influences of molecular mass of hyaluronic acid and lyophilization on transfection efficiency.
Sato T; Nakata M; Yang Z; Torizuka Y; Kishimoto S; Ishihara M
J Gene Med; 2017 Aug; 19(8):. PubMed ID: 28667693
[TBL] [Abstract][Full Text] [Related]
17. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.
Zeng P; Xu Y; Zeng C; Ren H; Peng M
Int J Pharm; 2011 Aug; 415(1-2):259-66. PubMed ID: 21645597
[TBL] [Abstract][Full Text] [Related]
18. The effect of CpG motifs on gene expression and clearance kinetics of aerosol administered polyethylenimine (PEI)-plasmid DNA complexes in the lung.
Lesina E; Dames P; Rudolph C
J Control Release; 2010 Apr; 143(2):243-50. PubMed ID: 20074600
[TBL] [Abstract][Full Text] [Related]
19. In vivo gene transfer using pDNA/chitosan/chondroitin sulfate ternary complexes: influence of chondroitin sulfate on the stability of freeze-dried complexes and transgene expression in vivo.
Hagiwara K; Kishimoto S; Ishihara M; Koyama Y; Mazda O; Sato T
J Gene Med; 2013 Feb; 15(2):83-92. PubMed ID: 23307647
[TBL] [Abstract][Full Text] [Related]
20. Development of New Formulation Dry Powder for Pulmonary Delivery Using Amino Acids to Improve Stability.
Suzuki Y; Okuda T; Okamoto H
Biol Pharm Bull; 2016; 39(3):394-400. PubMed ID: 26725531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
